Login / Signup

The reversion variant (p.Arg90Leu) at the evolutionarily adaptive p.Arg90 site in CELA3B predisposes to chronic pancreatitis.

Emmanuelle MassonVinciane ReboursLouis BuscailFrédérique FreteMael PagenaultAlain LachauxJean-Baptiste ChevauxEmmanuelle GéninDavid N CooperClaude FérecJian-Min Chen
Published in: Human mutation (2021)
A gain-of-function missense variant in the CELA3B gene, p.Arg90Cys (c.268C>T), has recently been reported to cause pancreatitis in an extended pedigree. Herein, we sequenced the CELA3B gene in 644 genetically unexplained French chronic pancreatitis (CP) patients (all unrelated) and 566 controls. No obvious loss-of-function variants were identified. None of the six low-frequency or common missense variants detected showed significant association with CP. Nor did the aggregate rare/very rare missense variants (n = 14) show any significant association with CP. However, p.Arg90Leu (c.269G>T), which was found in four patients but no controls, and affects the same amino acid as p.Arg90Cys, serves to revert p.Arg90 to the human elastase ancestral allele. As p.Arg90Leu has previously been shown to exert a similar functional effect to that of p.Arg90Cys, our findings not only confirm the involvement of CELA3B in the etiology of CP but also pinpoint a new evolutionarily adaptive site in the human genome.
Keyphrases
  • copy number
  • end stage renal disease
  • chronic kidney disease
  • ejection fraction
  • endothelial cells
  • newly diagnosed
  • genome wide
  • prognostic factors
  • intellectual disability
  • amino acid
  • induced pluripotent stem cells